Thermo Fisher Scientific (NYSE: TMO) reported Q2 EPS of $6.03, $0.31 better than the analyst estimate of $5.72. Revenue for the quarter came in at $11.99 billion versus the consensus estimate of $11.71 billion.

For earnings history and earnings-related data on Thermo Fisher Scientific (TMO) click here.